Compare McKesson Corporation (MCK) vs Marqeta Inc (MQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Marqeta Inc — how do they compare? McKesson Corporation trades at $828.8 (market cap $97.35B), while Marqeta Inc trades at $17.19 (market cap $1.85B). The key difference: McKesson Corporation is far larger — about 52.6× Marqeta Inc's market cap, and McKesson Corporation pays a 0.39% dividend while Marqeta Inc pays none. Which is the better fit depends on your goals.
| MCK | MQ | |
|---|---|---|
Market Cap | $97.35B | $1.85B |
Sector | Health | Technology |
52-Week High | $995.69 | $27.32 |
52-Week Low | $659.01 | $15.04 |
Enterprise Value | $101.98B | $1.15B |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Marqeta (MQ) trades at $17.45, down slightly by 0.23% today. The stock shows a bullish technical signal with strong moving average support, though RSI levels indicate mixed momentum. Fundamentally, the company reported revenue of $624.88M in 2025 (source: company filing 2025) but a net loss of $13.93M, with profitability metrics like net margin at 0.33% remaining thin. A recent 1-for-4 reverse stock split was effective July 1, 2026 (source: Business Wire 2026-06-29), aimed at boosting the share price amid restructuring efforts.
The outlook is cautiously optimistic with analyst consensus price target at $19.00 (source: MarketBeat 2026), implying potential upside, but high valuation ratios (P/E 436.88) and ongoing profitability challenges pose risks. Investor sentiment is mixed, balancing growth initiatives in Europe against competitive and operational headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Marqeta Inc
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →
